ABCAM PLC-SPON ADR (ABCM) Stock Price, Quote, News and Overview
NASDAQ:ABCM - Nasdaq - US0003802040 - ADR - Currency: USD
ABCM Quote, Performance and Key Statistics
23.99
+0.01 (+0.04%)
The current stock price of ABCM is 23.99 USD. In the past month the price increased by 3.05%. In the past year, price increased by 54.57%.
ABCM Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 19.97 | 357.10B | ||
| AMGN | AMGEN INC | 15.29 | 162.72B | ||
| GILD | GILEAD SCIENCES INC | 23.85 | 137.00B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 1669.79 | 124.40B | ||
| REGN | REGENERON PHARMACEUTICALS | 15.34 | 76.56B | ||
| ARGX | ARGENX SE - ADR | N/A | 39.16B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 32.32B | ||
| BNTX | BIONTECH SE-ADR | N/A | 28.77B | ||
| ONC | BEIGENE LTD-ADR | N/A | 27.25B | ||
| NTRA | NATERA INC | N/A | 21.43B | ||
| BIIB | BIOGEN INC | 8.54 | 20.49B | ||
| SMMT | SUMMIT THERAPEUTICS INC | N/A | 16.31B |
Related stock screener links
About ABCM
Company Profile
Abcam Plc is a global life science company, which distributes antibodies and associated protein research tools. The company is headquartered in Cambridge, Cambridgeshire and currently employs 1,750 full-time employees. The company went IPO on 2005-11-03. The firm is engaged in the identification, development and distribution of biological reagents. The Company’s products are used by various researchers worldwide to study biological pathways critical for scientific research, diagnostics and drug discovery. Its products can be grouped into two categories: research use only (RUO) proteomic tools and antibodies for clinical application. RUO products include protein binding reagents, such as antibodies and immunoassays, and related reagents. Its RUO products are used to detect, quantify, visualize and modify proteins in scientific research experiments, serving as vital tools to enable its customers to develop insights about targets and biological pathways of interest. Antibodies are a core component of many in vitro diagnostic assays and can also be used as therapeutic agents to treat various diseases, including cancer.
Company Info
ABCAM PLC-SPON ADR
Discovery Drive, Cambridge Biomedical Campus, Hills Road
Cambridge CAMBRIDGESHIRE CB2 0AX GB
CEO: Alan Hirzel
Employees: 1750
Company Website: http://www.abcam.com/
Phone: 441223696000.0
ABCAM PLC-SPON ADR / ABCM FAQ
What is the stock price of ABCAM PLC-SPON ADR today?
The current stock price of ABCM is 23.99 USD. The price increased by 0.04% in the last trading session.
What is the ticker symbol for ABCAM PLC-SPON ADR stock?
The exchange symbol of ABCAM PLC-SPON ADR is ABCM and it is listed on the Nasdaq exchange.
On which exchange is ABCM stock listed?
ABCM stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for ABCAM PLC-SPON ADR stock?
15 analysts have analysed ABCM and the average price target is 20.23 USD. This implies a price decrease of -15.68% is expected in the next year compared to the current price of 23.99. Check the ABCAM PLC-SPON ADR stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is ABCAM PLC-SPON ADR worth?
ABCAM PLC-SPON ADR (ABCM) has a market capitalization of 5.49B USD. This makes ABCM a Mid Cap stock.
How many employees does ABCAM PLC-SPON ADR have?
ABCAM PLC-SPON ADR (ABCM) currently has 1750 employees.
What are the support and resistance levels for ABCAM PLC-SPON ADR (ABCM) stock?
ABCAM PLC-SPON ADR (ABCM) has a support level at 23.96 and a resistance level at 24.47. Check the full technical report for a detailed analysis of ABCM support and resistance levels.
Is ABCAM PLC-SPON ADR (ABCM) expected to grow?
The Revenue of ABCAM PLC-SPON ADR (ABCM) is expected to grow by 24.37% in the next year. Check the estimates tab for more information on the ABCM EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy ABCAM PLC-SPON ADR (ABCM) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of ABCM, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of ABCM, evaluating the profitability, health, valuation and growth aspects
- ABCAM PLC-SPON ADR (ABCM) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- ABCAM PLC-SPON ADR (ABCM) Sales and EPS estimates to see what analysts future expectations are.
- ABCAM PLC-SPON ADR (ABCM) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- ABCAM PLC-SPON ADR (ABCM) Insider and Institutional Ownership to learn about the owners and their transactions.
- ABCAM PLC-SPON ADR (ABCM) Stock Chart to make your own analysis
- ABCAM PLC-SPON ADR (ABCM) Latest news and press-releases to stay up to date.
Does ABCAM PLC-SPON ADR (ABCM) stock pay dividends?
ABCM does not pay a dividend.
What is the Price/Earnings (PE) ratio of ABCAM PLC-SPON ADR (ABCM)?
The PE ratio for ABCAM PLC-SPON ADR (ABCM) is 44.43. This is based on the reported non-GAAP earnings per share of 0.54 and the current share price of 23.99 USD. Check the full fundamental report for a full analysis of the valuation metrics for ABCM.
ABCM Technical Analysis
ChartMill assigns a technical rating of 10 / 10 to ABCM. When comparing the yearly performance of all stocks, ABCM is one of the better performing stocks in the market, outperforming 89.33% of all stocks.
ABCM Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to ABCM. While ABCM has a great profitability rating, there are some minor concerns on its financial health.
ABCM Financial Highlights
Over the last trailing twelve months ABCM reported a non-GAAP Earnings per Share(EPS) of 0.54. The EPS increased by 402.64% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 1.94% | ||
| ROA | 0.64% | ||
| ROE | 0.93% | ||
| Debt/Equity | 0.3 |
ABCM Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 80% to ABCM. The Buy consensus is the average rating of analysts ratings from 15 analysts.
For the next year, analysts expect an EPS growth of 125.95% and a revenue growth 24.37% for ABCM